Chongqing (1)

EGFR G719X (1)

EGFR L861Q (1)

EGFR S768I (1)

Non-small Cell Lung Cancer (1)

Recruiting (1)

phase 2 (1)

Chongqing University Cancer Hospital (1)

Army Specialty Medical Center (1)

The Second Affilicated Hospital of Chongqing Medical University (1)

furmonertinib 160 mg, q.d. (1)

drug (1)

Other (1)

Interventional (1)

egfr l861q

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Sep 16, 2022